A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 2,124 shares of MEDP stock, worth $854,697. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,124
Previous 1,073 97.95%
Holding current value
$854,697
Previous $329 Million 160.94%
% of portfolio
0.22%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $299,398 - $434,388
1,051 Added 97.95%
2,124 $858 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $244,128 - $335,505
1,073 New
1,073 $329 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.